Stay updated on HER2+ Breast Cancer Adjuvant Trial
Sign up to get notified when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.

Latest updates to the HER2+ Breast Cancer Adjuvant Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check28 days agoChange DetectedThe study on HER2-positive early breast cancer has been updated to reflect a new patient allocation of approximately 520 instead of 700, and the hospital name has changed from Helsinki University Central Hospital to Helsinki University Hospital. Additionally, the last update date has been revised to February 2025.SummaryDifference2%
- Check35 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check42 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check57 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check64 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
Stay in the know with updates to HER2+ Breast Cancer Adjuvant Trial
Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Adjuvant Trial page.